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A majority of patients with facioscapulohumeral muscular dystrophy (FSHD) report
severe fatigue. The aim of this study was to explore whether fatigability during a
performance task is related to the main clinical features of the disease in mildly affected
patients. A total of 19 individuals with a molecular genetic-based diagnosis of FSHD
(median D4Z4 deletion length of 27 kb) performed two isometric flexions of the dominant
biceps brachii at 20% of their maximal voluntary contraction (MVC) for 2 min, and
then at 60% MVC until exhaustion. Fatigability indices (average rectified value, mean
frequency, conduction velocity, and fractal dimension) were extracted from the surface
electromyogram (sEMG) signal, and their correlations with age, age at onset, disease
duration, D4Z4 contraction length, perceived fatigability, and clinical disability score
were analyzed. The conduction velocity during the low level contraction showed a
significant negative correlation with the age at onset (p < 0.05). This finding suggest the
assessment of conduction velocity at low isometric contraction intensities, as a potential
useful tool to highlight differences in muscle involvement in FSHD patients.
Keywords: neuromuscular disease, dystrophy, electromyography, fatigability, D4Z4, correlation, muscle fiber
conduction velocity
INTRODUCTION
Facioscapulohumeral dystrophy (FSHD) is the third most common hereditary myopathy
worldwide, with an estimated prevalence of 1/15,000–1/20,000 (Mostacciuolo et al., 2009). The
clinical heterogeneity of FSHD makes it difficult to predict the disease course; diagnosis depends on
a combination of genetic and clinical features (Lemmers et al., 2012) and eventually, exclusion of
other similar disorders. Diagnosis is facilitated by the fact that in most patients there is contraction
in the DNA fragment on chromosome 4q35 containing the 3.3-kb D4Z4 repeat (Wijmenga et al.,
1992; van Deutekom et al., 1993). The classical clinical presentation of FSHD includes asymmetric
sequential face and shoulder girdle weakness followed by weakness in the foot extensor, abdominal,
and hip girdle muscles caused by atrophy and fatty infiltration (Zampatti et al., 2019). The clinical
features of FSHD were shown to be correlated with sex and age of onset (Zernov and Skoblov, 2019).
Moreover, several genotype–phenotype correlation studies reported a rough inverse correlation
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between the number of D4Z4 repeats and the severity of FSHD
(Lunt et al., 1995; Tawil et al., 1996; Ricci et al., 1999). However,
more recent publications did not find satisfactory correlations,
even using a large number of patients (Ruggiero et al., 2020;
Salort-Campana et al., 2020; Vercelli et al., 2021).
In addition to muscle deterioration, severe fatigue is reported
by a majority of FSHD patients (Hamel et al., 2019) and is an
early manifestation of the disease that constrains the performance
of common daily activities (Schipper et al., 2017). Despite its
prevalence, fatigue in FSHD has not been adequately investigated
and the extent to which performance and perceived fatigability
limit cognitive and physical functions in patients is unknown
(Kluger et al., 2013). Performance fatigability refers to a decline
in objective measures of performance such as the production of
maximal voluntary force, ability to provide an adequate signal
to voluntarily activated muscle, and involuntary twitch response
to stimulation (Enoka and Duchateau, 2016); it can be assessed
by surface electromyography (sEMG) using spectral parameters,
muscle fiber conduction velocity (CV), or nonlinear parameters
(Rampichini et al., 2020). Fatigue during isometric constant force
contractions is reflected by a decrease in CV mainly related to a
change in intracellular pH (Komi and Tesch, 1979). A reduction
in the fractal dimension (FD) of the sEMG signal has been linked
to fatigability, aging, and disease (Goldberger et al., 2002; Arjunan
and Kumar, 2013; Beretta-Piccoli et al., 2021), and is a useful
index for assessing performance fatigability.
To date there have been no studies on the relationship
between performance fatigability and genetic (e.g., D4Z4
allele size) and clinical (e.g., FSHD score) aspects of the
disease. To address this issue, the present study investigated
whether indices of performance fatigability extracted from the
sEMG signal can predict the genetic and clinical features of
patients with mild FSHD.
MATERIALS AND METHODS
Participants
The study was part of a crowdfunded project (#Sport4therapy)
carried out at the CRIAMS-Sport Medicine Centre Voghera
supported by the University of Pavia that was aimed at identifying
the correct sports therapy approach for patients affected by
FSHD (Berardinelli and D’Antona, 2019). Data collection started
in 2013 and was completed in 2019 (Beretta-Piccoli et al.,
2021). Inclusion criteria were as follows: age of ≥ 16 years;
clinical or genetic diagnosis of FSHD; and enrollment in the
Italian National Registry for FSHD. Exclusion criteria were as
follows wheelchair-bound at selection; use of corticosteroids;
severe cardiac and respiratory dysfunction; and psychological or
psychiatric disorders.
A diagnosis of FSHD was confirmed by DNA testing
(Lemmers et al., 2012) at the University of Modena and Reggio
Emilia (Modena, Italy). Disease severity was determined by
FSHD clinical score (Lamperti et al., 2010), which ranges from
0 (no sign of functional impairment) to 15 (severe impairment of
all tested muscle groups and wheelchair dependency). The scale
is divided into six independent sections that assess the strength
and functionality of facial (score 0–2), scapular girdle (score 0–3),
upper limb (score 0–2), distal leg (score 0–2), pelvic girdle (score
0–5), and abdominal (score 0–1) muscles.
Patients were allocated to the four clinical categories of the
Comprehensive Clinical Evaluation Form (Ricci et al., 2016),
which classifies subjects presenting facial and scapular girdle
muscle weakness (category A); subjects with muscle weakness
limited to the scapular girdle or facial muscles (category B);
asymptomatic or healthy subjects (category C); and subjects with
a myopathic phenotype presenting clinical features not consistent
with the canonical FSHD phenotype (category D).
Asymmetry of muscle involvement was clinically evaluated
and patients with predominantly right or left side involvement
were compared to determine whether side involvement was
correlated with disease severity. Significant asymmetry (right-
side predominance) in upper extremity muscle involvement was
previously observed that was independent of handedness (Rijken
et al., 2014). The participants’ characteristics are listed in Table 1.
All subjects provided written, informed consent to participate
in this study, which was conducted according to the Declaration




The fatigue severity subscale of the Checklist Individual Strength
(CIS-fatigue) was used to assess trait levels of perceived
fatigability before task performance. The CIS-fatigue consists of
TABLE 1 | Clinical summary.
n Median IQR
Characteristics
Gender Woman 10 – –
Man 9 – –
Age (years) – 33.50 31.25
Age at onset (years) – 15.00 20.00
Disease duration (years) – 10.00 23.00
FSHD categories A 14 – –
B 3 – –
D 2 – –
FSHD asymmetry Right > Left 10 – –
Right = Left 6 – –
Right < Left 3 – –






D4Z4 contraction (kb) – 27.00 11.50
Checklist individual strengtha – 26.00 15.00
Severity of FSHD (clinical score) – 4.00 6.25
Scapular girdle involvement score 2.00 1.00
aVariable with 3 missing values (n = 16). FSHD, facioscapulohumeral muscular
dystrophy; IQR, interquartile range.
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eight questions regarding fatigue experienced in the previous
2 weeks; each question was scored on a 7-point Likert scale
(Vercoulen et al., 1994), with a total score ≥ 35 indicating
severe fatigue (Vercoulen et al., 1996). The CIS-fatigue has
good internal consistency (Cronbach’s α = 0.83–0.92), high
discriminant validity, and high sensitivity to change in patients
with FSHD (Kalkman et al., 2007).
Performance Fatigability
Performance fatigability was evaluated in FSHD patients
as previously described (Beretta-Piccoli et al., 2017, 2020,
2021). Briefly, participants performed two maximal voluntary
contractions (MVC) separated by 2 min rest, followed by a 20%
MVC contraction lasting 2 min and a 60% MVC held until the
force level decreased to < 90% of the target (endurance time).
The two submaximal contractions were separated by 5 min rest.
Because arm muscles show early disability in FSHD (Derry et al.,
2012; Rijken et al., 2014; Tawil, 2018), the biceps brachii was
selected for testing. Submaximal contractions were analyzed as
their intensity is more representative of that associated with the
performance of activities of daily living.
EMG and Force Measurements
Myoelectric signals in the dominant biceps brachii were detected
in monopolar configuration. Participants were seated on a height-
adjustable chair with their arm positioned on an isometric
ergometer (MUC1; OT-Bioelettronica, Turin, Italy) equipped
with a load cell (Model TF022; CCT Transducers, Turin,
Italy). The wrist was fastened to the ergometer, with the
elbow flexed at 120◦. A bidimensional array of 64 electrodes
(3 mm diameter, 8 × 8 grid, 10 mm interelectrode distance)
(model ELSCH064NM3; OT-Bioelettronica) was positioned on
the biceps brachii as previously described (Beretta-Piccoli et al.,
2020). The ground electrode was placed on the contralateral wrist.
Elbow torque was assessed using a torque meter operating
linearly in the range of 0–1,000 Nm. The torque signal was
amplified (MISO II; OT-Bioelettronica) and saved on a computer.
EMG signals were amplified by a variable factor ranging from
2,000 to 5,000 (EMG-USB2+; OT-Bioelettronica), filtered with
the hardware filter (10–500 Hz bandpass) followed by an offline
Butterworth anticausal bandpass filter, and sampled together with
the torque signal at 2,048 Hz using a 16-bit A/D converter with
5-V dynamic range and saved on a computer. The torque signal
was displayed on a screen as real-time biofeedback.
Signal Processing
The channels used for CV estimation were selected based on
visual inspection of single differential signals along one of the
array columns as previously described (Beretta-Piccoli et al.,
2017); numbers typically ranged from 4 to 7 (Farina et al.,
2004). CV was estimated using a multichannel algorithm (Farina
and Merletti, 2003) on single differential signals using non-
overlapping signal epochs of 1 s on the selected channels. Each of
the selected signal epochs was used to estimate average rectified
value (ARV), mean frequency of the power spectrum (MNF), and
FD of the sEMG signal; these variables were averaged across all
selected channels. ARV (a measure of the amplitude) and MNF
(a parameter used to quantify changes in the spectral content of
the sEMG signal based on the Fourier transform) were computed
offline with numerical algorithms (Merletti et al., 1990). FD was
estimated using the box-counting method (Gitter and Czerniecki,
1995). Performance fatigability was indirectly quantified as the
slope of sEMG variables during the contractions.
Statistical Analysis
Linear regression over time was applied to ARV, MNF, CV, and
FD and the slopes were extracted and normalized with respect to
their initial values. A Shapiro–Wilk test revealed that the variable
distributions deviated from normality; consequently, the analyses
were conducted using nonparametric statistical indicators.
Relationships between continuous variables were investigated
with Spearman’s correlation coefficient. Differences in fatigability
parameters in relation to sex, FSHD categories, asymmetry
of muscle involvement, and scapular girdle involvement score
were assessed with the Mann–Whitney U-test. The statistical
significance was set at α = 0.05. All statistical analyses were
carried out with Stata/IC v16.0 (StataCorp, College Station,




Of the 19 patients, 14 belonged to category A and presented facial
and scapular girdle muscle weakness (Ricci et al., 2016). Muscle
weakness was more pronounced on the right side in 10 patients, 9
of whom were right-handed (Table 1); in 3 patients the weakness
was greater on the left side and in 6, both sides showed equal
weakness. The number of patients per D4Z4 contraction/number
of repeats is shown in Table 1. The median FSHD clinical
score was 4 (IQR = 6.25), indicating mild involvement of facial,
scapular girdle, and upper limb muscles. The median scapular
girdle involvement score was 2 (IQR = 1), suggesting moderate
involvement with limitations in arm abduction (>45◦ but <180◦)
(Lamperti et al., 2010). Perceived fatigability as measured with the
CIS-fatigue was mild (26 [IQR = 15]). The median MVC at 60◦ of
isometric elbow flexion was 20.28 kg [IQR = 18.59].
Correlation Analysis Between Fatigability
and Clinical Variables
No significant correlation was observed between age, age at
onset, disease duration, D4Z4 deletion length, CIS-fatigue score,
clinical severity score, and rates of change in ARV, MNF, and
FD. On the contrary, the rate of change of CV during the 20%
MVC contraction significantly correlated with the age at onset
(rho = −0.51, p < 0.05). When patients with borderline length of
D4Z4 contraction (9–10 repeats) were excluded from the analysis,
the significance dramatically increased (rho = −0.81; p < 0.001;
Figure 1).
Within patients with a minimal D4Z4 contraction (1–5 alleles,
n = 9), the following significant correlations were observed: (1)
age with CV during the 60% MVC (rho = 0.86; p < 0.05); (2)
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FIGURE 1 | Relationship between the age at onset and muscle fiber conduction velocity (CV) slope during the 20% maximal voluntary contraction (MVC) of the
biceps brachii. The slope was normalized with respect to the initial values. R2 = 0.29, y = 0.09–5.48E-3*x.
TABLE 2 | Spearman correlation coefficients between the continuous variables.
% of the maximal voluntary
isometric contraction
Age Age at onset Disease duration D4Z4 CIS FSHD_CS
D4Z4 0.2421 0.1697
CISa 0.0627 0.2818 0.0787 0.2045
FSHD_CS 0.0840 0.0676 0.1142 −0.1952 0.0210
ARV slope 20% 0.1537 0.1767 −0.1041 −0.0908 −0.0712 −0.0458
60% −0.0023 0.0572 0.1756 −0.0326 −0.2822 0.0371
MNF slope 20% 0.0603 −0.0176 −0.0071 0.1590 −0.1153 −0.3775
60% 0.2945 0.3017 0.2118 0.0689 0.2172 −0.0396
CV slopeb 20% −0.1416 −0.5080* −0.0333 0.0781 −0.2049 0.1287
60% 0.1323 0.1587 0.1272 −0.0989 0.0086 0.1040
FD slope 20% −0.0701 0.0149 −0.0485 0.0341 −0.0491 −0.2451
60% 0.1461 0.2621 0.1959 −0.0114 0.2380 −0.0569
MVCc −0.3366 −0.0232 −0.4491 0.2295 −0.1736 −0.3553
CV sloped 60% 0.857*
MVCd −0.766* −0.854**
*p < 0.05 and **p < 0.01.
aVariables with 2 missing values (n = 17 instead of 19).
bVariables with 1 missing value (n = 18 instead of 19).
cVariables with 4 missing values (n = 15 instead of 19).
dOnly patients with RU 1–5 were considered (n = 9 instead of 19).
ARV, averaged rectified value; MNF, mean frequency of the power spectrum; CV, conduction velocity; FD, fractal dimension; D4Z4, deletion length; CIS, checklist individual
strength; CS, clinical score.
age with MVC (rho = −0.77; p < 0.05); (3) disease duration with
MVC (rho = −0.85; p < 0.01; Table 2).
Differences in Fatigability According to
Sex, FSHD Category, Asymmetry of
Muscle Involvement, and Scapular Girdle
Involvement Score
Because of the small sample size, in order to facilitate the
assessment of differences in clinical variables we recoded FSHD
category, asymmetry, and scapular girdle involvement score as
binary variables [“A” and “Not A”; “Right > Left” and “Not
right > Left”; and “normal abduction” (score 0–1) and “impaired
abduction” (score 2–3), respectively]. There were no statistically
significant differences in the performance fatigability parameters
and maximal force according to sex, FSHD asymmetry, or
scapular girdle involvement score. However, the median slope
of MNF and FD during the 60% MVC contraction differed
significantly between the A and Not A categories of FSHD
(p = 0.026; Figure 2).
DISCUSSION
This study investigated (1) whether sEMG parameters that are
indirect indices of performance fatigability are correlated with
clinical variables of FSHD patients; and (2) the relationship
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FIGURE 2 | Box-and-whisker plots of slopes of average rectified value (ARV), mean power spectrum frequency (MNF), conduction velocity (CV) and fractal
dimension (FD) during the 20 and 60% maximal voluntary contractions. Slopes were normalized with respect to their initial values. Asterisks denote statistical
significance at ∗p < 0.05. Categories definition see text.
between fatigability parameters and sex, FSHD category,
asymmetry of muscle involvement, and scapular girdle
involvement score. The results showed a significant correlation
between muscle fiber CV and the age at onset. Moreover,
a decrease in the slopes of MNF and FD during endurance
contraction was observed in patients in category A compared to
those in categories B and D (Not A).
Relationship Between Fatigability and
Clinical Variables
Age at Onset
In this study, we established that a late age at onset was associated
with a more negative slope of muscle fiber CV, during the
20% MVC isometric elbow flexion, particularly in patients with
1–8 alleles. Patients with borderline D4Z4 contractions may
have more mild phenotypes and older age at onset (Statland
et al., 2015). In a previous publication on the same patients,
we showed that this contraction level was not fatiguing, as
the slope of CV was not different from zero (Beretta-Piccoli
et al., 2021). Considering that at low level of muscle contraction
graded recruitment prevails on rate coding to maintain the force
(Milner-Brown et al., 1973), the observed negative correlation
may mirror the overall lower deterioration of fast twitch fibers
and/or fast to slow switch in biceps brachii when the disease
clinical onset occurs later in life. Indeed, this finding identifies
the assessment of CV at low % MVC isometric contraction
as a potential useful tool to highlight differences in muscle
involvement in FSHD patients.
D4Z4 Contraction and Clinical Score
No significant correlation was observed between D4Z4
contraction length and clinical variables or performance
fatigability parameters. Although this has not been previously
investigated, a negative correlation between muscle computed
tomography grade and D4Z4 fragment size has been reported
(Wang et al., 2012). Radiologic severity was shown to be
unrelated to the size of the D4Z4 array (Olsen et al., 2006),
but a correlation between the number of D4Z4 repeats
and isokinetic peak torque of trunk extensors and flexors
has been demonstrated (Esnault et al., 2018). Moreover,
D4Z4 repeat size was shown to be correlated with total
score for a manual muscle test (Sacconi et al., 2019). The
observed variability in the correlation results may be related
to the mean deletion length (Scionti et al., 2012). In fact, a
borderline number of D4Z4 repeats (between 8 and 10) showed
no association with the severity of clinical manifestations
(Zernov and Skoblov, 2019).
Interestingly, within minimal D4Z4 contraction (1–5
repeats), the age of the patients showed significant correlations
with the slope of the muscle fiber CV during the 60% MVC
contraction, as well as with the MVC, suggesting that elderly
patients are less prone to get fatigued, but at the same time
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generate lower levels of maximal force. Similarly, disease
duration was negatively correlated to the exerted maximal
force. In healthy subjects it is well known that a correlation
between muscle fiber CV and age, characterized by a tendency
of delay due to age, both during MVC and submaximal
contractions, exists (Merletti et al., 1992; Hara et al., 1998;
Bilodeau et al., 2001; Yamada et al., 2002; Bazzucchi et al.,
2005; Mase et al., 2006). Differences between younger
and older subjects become more apparent as motor units
(MUs) recruitment becomes complete. In fact, the fast
twitch, rapidly fatiguing fibers, being the later recruited
MUs, are those more affected by the aging process. This is
in agreement with the hypothesis that in older individuals,
slow twitch fibers are predominant (D’Antona et al., 2003).
Accordingly, reduction in maximal force in adult aging
may be associated with alterations to the neuromuscular
system, that affect the muscle fiber, the neuromuscular
junction and the innervating motor neurons (Rice and
Cunningham, 2002; Klass et al., 2007; Hunter et al., 2016).
Data from the present investigation appear to corroborate
the hypothesis that duration of the disease is a critical factor
late deterioration of muscle force and fibers composition
transition toward a slower phenotype and that this phenomenon
appears to sum to the expected physiological change due to
the aging process.
Perceived Fatigability
In line with previous findings in patients with FSHD (Schillings
et al., 2007) or other neuromuscular disorders such as multiple
sclerosis (e.g., Dodd et al., 2011; Wolkorte et al., 2015a; Severijns
et al., 2016; Beretta-Piccoli et al., 2020), performance fatigability
showed no correlation with clinical parameters. This may be
because the patients in our study were not severely fatigued (CIS-
fatigue < 35). Age and MVC values were shown to have positive
and negative effects, respectively, on performance fatigability
(Wolkorte et al., 2015b); these variables interact with each other
and can interfere with the association between perceived and
performance fatigability (Romani et al., 2004).
Influence of Sex, FSHD Category,
Asymmetry of Muscle Involvement, and
Scapular Girdle Involvement Score on
Fatigability
Performance fatigability parameters did not differ significantly
according to most of the considered variables (sex, asymmetry,
and scapular girdle involvement score). However, the slopes
of MNF and FD during the endurance contraction differed
between the two categories of FSHD (A and Not A), suggesting
that patients with facial and scapular girdle muscle weakness
experienced greater fatigue during isometric elbow flexion
compared to the other patients. The two categories share
pathophysiologic traits including impaired abduction of the
upper limb with winged scapula and varying degrees of facial
weakness (Ricci et al., 2016), which reflect a worsening phenotype
(Vercelli et al., 2021). Importantly, the greater declines in the
slopes of MNF (which is related to decreased muscle fiber CV
and increased MU firing rate and synchronization (Bigland-
Ritchie and Woods, 1984; Brody et al., 1991; Gabriel and Kamen,
2009) and FD (which is related to increased MU firing rate
and synchronization Rampichini et al., 2020) suggest that the
difference in fatigability between A and Not A is mainly due
to central factors. This is supported by the results obtained for
ARV and CV, which were altered during submaximal isometric
contractions mostly as a result of peripheral factors (Dimitrova
and Dimitrov, 2002, 2003; Dimitrov et al., 2006).
LIMITATIONS
This study had some limitations. Firstly, the statistical power
was low because of the small sample size. Therefore, the
results should be considered as exploratory and confirmed in a
larger cohort. Secondly, as the assessment of fatigability is task-
dependent (Enoka, 1995), protocol specifications can affect the
findings regarding the mechanisms underlying fatigue. Thirdly,
we evaluated fatigability in the dominant biceps brachii only,
which may not be representative of the disease as a whole and
lastly, perceived fatigability is attributed to the whole body and
does not necessarily correspond to fatigue in specific muscles.
CONCLUSION
The length of D4Z4 contraction was not associated with disease
severity or fatigability, indicating that unknown environmental
factors have a significant impact on the genotype–phenotype
interactions underlying clinical manifestations. However, trends
in the fatigability parameters suggest more prominent fatigue in
patients with a typical phenotype (category A) compared to other
patient subsets.
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